The epidemiologic and clinical importance of norovirus infection.

PubWeight™: 2.49‹?› | Rank: Top 2%

🔗 View Article (PMID 16880066)

Published in Gastroenterol Clin North Am on June 01, 2006

Authors

Robert L Atmar1, Mary K Estes

Author Affiliations

1: Department of Medicine, Baylor College of Medicine, 1 Baylor Plaza, MS BCM280, Houston, TX 77030, USA. ratmar@bcm.edu

Articles citing this

Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70

Viral shape-shifting: norovirus evasion of the human immune system. Nat Rev Microbiol (2010) 2.53

Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21

Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog (2010) 1.88

Evaluation of removal of noroviruses during wastewater treatment, using real-time reverse transcription-PCR: different behaviors of genogroups I and II. Appl Environ Microbiol (2007) 1.85

Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med (2010) 1.73

Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol (2011) 1.73

Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J Virol (2011) 1.53

A mouse model for human norovirus. MBio (2013) 1.51

Aichi virus, norovirus, astrovirus, enterovirus, and rotavirus involved in clinical cases from a French oyster-related gastroenteritis outbreak. J Clin Microbiol (2008) 1.50

Replication of human noroviruses in stem cell-derived human enteroids. Science (2016) 1.44

Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination. J Pediatric Infect Dis Soc (2012) 1.42

Mouse norovirus replication is associated with virus-induced vesicle clusters originating from membranes derived from the secretory pathway. J Virol (2009) 1.41

Noroviruses - State of the Art. Food Environ Virol (2010) 1.39

A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence. J Virol (2012) 1.37

Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo. J Virol (2012) 1.34

Norovirus excretion in an aged-care setting. J Clin Microbiol (2008) 1.27

Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics (2010) 1.26

Fecal viral concentration and diarrhea in norovirus gastroenteritis. Emerg Infect Dis (2007) 1.25

Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20

Comprehensive analysis of a norovirus-associated gastroenteritis outbreak, from the environment to the consumer. J Clin Microbiol (2010) 1.20

Influence of novel norovirus GII.4 variants on gastroenteritis outbreak dynamics in Alberta and the Northern Territories, Canada between 2000 and 2008. PLoS One (2010) 1.20

Detection and quantification of noroviruses in shellfish. Appl Environ Microbiol (2008) 1.16

Multicenter comparison of two norovirus ORF2-based genotyping protocols. J Clin Microbiol (2009) 1.08

The prevalence of nosocomial and community acquired infections in a university hospital: an observational study. Dtsch Arztebl Int (2013) 1.06

VPg-primed RNA synthesis of norovirus RNA-dependent RNA polymerases by using a novel cell-based assay. J Virol (2011) 1.06

Distribution in tissue and seasonal variation of norovirus genogroup I and II ligands in oysters. Appl Environ Microbiol (2010) 1.05

Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope. J Virol (2007) 1.04

Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assay. Virology (2011) 1.04

Norovirus RNA synthesis is modulated by an interaction between the viral RNA-dependent RNA polymerase and the major capsid protein, VP1. J Virol (2012) 1.04

Molecular identification and genetic analysis of Norovirus genogroups I and II in water environments: comparative analysis of different reverse transcription-PCR assays. Appl Environ Microbiol (2007) 1.02

Enhanced detection and study of murine norovirus-1 using a more efficient microglial cell line. Virol J (2009) 1.02

Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol (2016) 1.01

Economic value of norovirus outbreak control measures in healthcare settings. Clin Microbiol Infect (2010) 0.98

In vitro whole-virus binding of a norovirus genogroup II genotype 4 strain to cells of the lamina propria and Brunner's glands in the human duodenum. J Virol (2011) 0.96

Identification of human single-chain antibodies with broad reactivity for noroviruses. Protein Eng Des Sel (2014) 0.95

Treatment of norovirus infections: moving antivirals from the bench to the bedside. Antiviral Res (2014) 0.94

Norovirus distribution within an estuarine environment. Appl Environ Microbiol (2009) 0.94

Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol (2010) 0.92

Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid. PLoS One (2013) 0.92

Concentration of norovirus during wastewater treatment and its impact on oyster contamination. Appl Environ Microbiol (2012) 0.91

Binding to histo-blood group antigen-expressing bacteria protects human norovirus from acute heat stress. Front Microbiol (2015) 0.87

Does spatial proximity drive norovirus transmission during outbreaks in hospitals? BMJ Open (2013) 0.85

Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II. J Clin Microbiol (2008) 0.85

Institutional risk factors for norovirus outbreaks in Hong Kong elderly homes: a retrospective cohort study. BMC Public Health (2011) 0.85

Lifting the lid on toilet plume aerosol: a literature review with suggestions for future research. Am J Infect Control (2012) 0.83

The burden of norovirus disease in children in the European Union. Pediatr Infect Dis J (2015) 0.82

Linking time-varying symptomatology and intensity of infectiousness to patterns of norovirus transmission. PLoS One (2013) 0.81

Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol (2014) 0.81

An inside job: subversion of the host secretory pathway by intestinal pathogens. Curr Opin Infect Dis (2010) 0.80

Norovirus Recombinant Strains Isolated from Gastroenteritis Outbreaks in Southern Brazil, 2004-2011. PLoS One (2016) 0.80

Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007. Epidemiol Infect (2011) 0.80

Evaluation of third-generation ELISA and a rapid immunochromatographic assay for the detection of norovirus infection in fecal samples from inpatients of a German tertiary care hospital. Eur J Clin Microbiol Infect Dis (2011) 0.80

Report of recombinant norovirus GII.g/GII.12 in Beijing, China. PLoS One (2014) 0.80

Epidemiology and Genetic Characterization of Noroviruses among Adults in an Endemic Setting, Peruvian Amazon Basin, 2004-2011. PLoS One (2015) 0.79

Pediatric norovirus infection. Eur J Clin Microbiol Infect Dis (2013) 0.78

Evidence-Based interventions of Norovirus outbreaks in China. BMC Public Health (2016) 0.78

Noroviruses in children seen in a hospital for acute gastroenteritis in Finland. Eur J Pediatr (2011) 0.77

Engineering Bacterial Surface Displayed Human Norovirus Capsid Proteins: A Novel System to Explore Interaction Between Norovirus and Ligands. Front Microbiol (2015) 0.77

Computational studies on the interaction of ABO-active saccharides with the norovirus VA387 capsid protein can explain experimental binding data. J Comput Aided Mol Des (2010) 0.77

Mechanisms of antiviral action of plant antimicrobials against murine norovirus. Appl Environ Microbiol (2014) 0.77

Anti-viral Effect of Bifidobacterium adolescentis against Noroviruses. Front Microbiol (2016) 0.76

Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirus. Protein Eng Des Sel (2016) 0.75

Viral etiologies of acute dehydrating gastroenteritis in pakistani children: confounding role of parechoviruses. Viruses (2015) 0.75

Molecular Evidence of Oysters as Vehicle of Norovirus GII.P17-GII.17. Emerg Infect Dis (2016) 0.75

In Situ Capture RT-qPCR: A New Simple and Sensitive Method to Detect Human Norovirus in Oysters. Front Microbiol (2017) 0.75

Prevalence of human norovirus and Clostridium difficile coinfections in adult hospitalized patients. Clin Epidemiol (2016) 0.75

The Where is Norovirus Control Lost (WINCL) Study: an enhanced surveillance project to identify norovirus index cases in care settings in the UK and Ireland. J Infect Prev (2015) 0.75

Community-based surveillance of norovirus disease: a systematic review. BMC Infect Dis (2017) 0.75

Articles by these authors

(truncated to the top 100)

Norovirus gastroenteritis. N Engl J Med (2009) 7.66

Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09

Laboratory efforts to cultivate noroviruses. J Gen Virol (2004) 4.41

Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87

Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78

Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70

Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15

Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol (2004) 2.83

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77

Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A (2008) 2.54

Rotavirus antigenaemia and viraemia: a common event? Lancet (2003) 2.51

Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50

The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol (2003) 2.38

Structural requirements for the assembly of Norwalk virus-like particles. J Virol (2002) 2.38

Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34

Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21

X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A (2006) 2.09

Rotaviruses: from pathogenesis to vaccination. Gastroenterology (2009) 2.05

Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med (2011) 2.04

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol (2003) 1.89

Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J Infect Dis (2007) 1.83

Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79

Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol (2005) 1.71

Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66

Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature (2012) 1.65

Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63

Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56

Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol (2005) 1.53

Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53

Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol (2006) 1.51

Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol (2014) 1.49

Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48

Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43

Rotavirus viremia and extraintestinal viral infection in the neonatal rat model. J Virol (2006) 1.43

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med (2010) 1.43

Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42

Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol (2002) 1.40

Burden of illness in the first 3 years of life in an Indian slum. J Trop Pediatr (2009) 1.40

Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology (2010) 1.40

X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution. J Virol (2006) 1.37

Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis (2006) 1.32

Autophagy hijacked through viroporin-activated calcium/calmodulin-dependent kinase kinase-β signaling is required for rotavirus replication. Proc Natl Acad Sci U S A (2012) 1.30

Stem cell-derived human intestinal organoids as an infection model for rotaviruses. MBio (2012) 1.27

Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics (2010) 1.26

Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis (2013) 1.23

Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20

Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J Virol (2006) 1.20

Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci U S A (2008) 1.15

Norwalk Virus Minor Capsid Protein VP2 Associates within the VP1 Shell Domain. J Virol (2013) 1.15

Rotavirus disrupts calcium homeostasis by NSP4 viroporin activity. MBio (2010) 1.13

Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection. J Virol (2002) 1.10

VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol (2002) 1.10

Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol (2011) 1.10

Golgi localization of ERManI defines spatial separation of the mammalian glycoprotein quality control system. Mol Biol Cell (2011) 1.08

Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine (2003) 1.08

Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J (2006) 1.07

Inhibition of cellular protein secretion by norwalk virus nonstructural protein p22 requires a mimic of an endoplasmic reticulum export signal. PLoS One (2010) 1.07

Norovirus vaccine development: next steps. Expert Rev Vaccines (2012) 1.03

The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol (2004) 1.01

Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs). Vaccine (2005) 1.01

Rotavirus non-structural proteins: structure and function. Curr Opin Virol (2012) 0.99

pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol (2005) 0.99

Structural basis of substrate specificity and protease inhibition in Norwalk virus. J Virol (2013) 0.98

Interleukin-8 gene regulation in intestinal epithelial cells infected with rotavirus: role of viral-induced IkappaB kinase activation. Virology (2002) 0.98

Epitope mapping and use of epitope-specific antisera to characterize the VP5* binding site in rotavirus SA11 NSP4. Virology (2007) 0.98

Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol (2012) 0.97

The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol (2013) 0.97

Two nonoverlapping domains on the Norwalk virus open reading frame 3 (ORF3) protein are involved in the formation of the phosphorylated 35K protein and in ORF3-capsid protein interactions. J Virol (2003) 0.96

Intanza(®): a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines (2010) 0.96

Geographic information systems and genotyping in identification of rotavirus G12 infections in residents of an urban slum with subsequent detection in hospitalized children: emergence of G12 genotype in South India. J Clin Microbiol (2006) 0.95

Genetic divergence of rotavirus nonstructural protein 4 results in distinct serogroup-specific viroporin activity and intracellular punctate structure morphologies. J Virol (2012) 0.93

Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response. PLoS Pathog (2010) 0.92

Interaction(s) of rotavirus non-structural protein 4 (NSP4) C-terminal peptides with model membranes. Biochem J (2004) 0.91

Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen. Clin Diagn Lab Immunol (2004) 0.91

Activation of the endoplasmic reticulum calcium sensor STIM1 and store-operated calcium entry by rotavirus requires NSP4 viroporin activity. J Virol (2013) 0.90

Expression of rotavirus NSP4 alters the actin network organization through the actin remodeling protein cofilin. J Virol (2007) 0.90

Adsorption and aggregation properties of norovirus GI and GII virus-like particles demonstrate differing responses to solution chemistry. Environ Sci Technol (2010) 0.89

Prestress strengthens the shell of Norwalk virus nanoparticles. Nano Lett (2011) 0.89

Human enteroids: preclinical models of non-inflammatory diarrhea. Stem Cell Res Ther (2013) 0.88

Rotavirus vaccines and pathogenesis: 2008. Curr Opin Gastroenterol (2009) 0.87

B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun (2005) 0.87

Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples. J Clin Microbiol (2013) 0.87

Crystallographic Analysis of Rotavirus NSP2-RNA Complex Reveals Specific Recognition of 5' GG Sequence for RTPase Activity. J Virol (2012) 0.86

Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia. Virology (2011) 0.86

Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses. J Virol (2014) 0.86

Viroporin-mediated calcium-activated autophagy. Autophagy (2013) 0.84

Synthesis and assembly of a cholera toxin B subunit-rotavirus VP7 fusion protein in transgenic potato. Mol Biotechnol (2005) 0.84

Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response. J Biotechnol (2005) 0.84

Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection. Clin Diagn Lab Immunol (2005) 0.84

Ricin toxin B subunit enhancement of rotavirus NSP4 immunogenicity in mice. Viral Immunol (2006) 0.83

Sequence analysis of the VP4, VP6, VP7, and NSP4 gene products of the bovine rotavirus WC3. Virus Genes (2002) 0.83

Rotavirus and biliary atresia: can causation be proven? Curr Opin Gastroenterol (2012) 0.82

Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity. J Virol (2008) 0.82

Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses. Virol J (2012) 0.82

Intestinal TSH production is localized in crypt enterocytes and in villus 'hotblocks' and is coupled to IL-7 production: evidence for involvement of TSH during acute enteric virus infection. Immunol Lett (2005) 0.82

A novel form of rotavirus NSP2 and phosphorylation-dependent NSP2-NSP5 interactions are associated with viroplasm assembly. J Virol (2013) 0.81

High efficiency cross-reactive monoclonal antibody production by oral immunization with recombinant norwalk virus-like particles. Microbiol Immunol (2006) 0.81

Synthesis of a ricin toxin B subunit-rotavirus VP7 fusion protein in potato. Mol Biotechnol (2006) 0.81

Rotavirus enterotoxin NSP4 has mucosal adjuvant properties. Vaccine (2010) 0.81

Oral immunization with a shiga toxin B subunit: rotavirus NSP4(90) fusion protein protects mice against gastroenteritis. Vaccine (2005) 0.81